CARLOS MANUEL
PANIZO SANTOS
University of British Columbia
Vancouver, CanadáPublicaciones en colaboración con investigadores/as de University of British Columbia (1)
2023
-
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Blood Advances, Vol. 7, Núm. 17, pp. 4926-4935